Adam Vogel
Stock Analyst at Craig-Hallum
(4.56)
# 983
Out of 4,639 analysts
36
Total ratings
79.3%
Success rate
39.1%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Adam Vogel
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATHE Alterity Therapeutics | Initiated Coverage: Buy | $12 | $4.55 | +164.03% | 1 | Aug 11, 2026 | |
| ACRS Aclaris Therapeutics | Maintained: Buy | $10 | $5.90 | +69.49% | 6 | Aug 6, 2026 | |
| PEPG PepGen | Maintained: Buy | $11 | $2.99 | +267.89% | 2 | Aug 6, 2026 | |
| DSGN Design Therapeutics | Maintained: Buy | $22 | $14.33 | +53.52% | 5 | Aug 4, 2026 | |
| MPLT MapLight Therapeutics | Maintained: Buy | $40 → $25 | $12.18 | +105.25% | 3 | Jul 28, 2026 | |
| APGE Apogee Therapeutics | Downgraded: Hold | $114 → $135 | $134.65 | +0.34% | 6 | Jun 22, 2026 | |
| IMNM Immunome | Rated: Buy | $36 | $25.69 | +40.13% | 8 | Jun 11, 2026 | |
| LBRX LB Pharmaceuticals | Rated: Buy | $36 | $45.85 | -21.48% | 4 | Jun 11, 2026 | |
| HIT Health In Tech | Maintained: Buy | n/a | $1.12 | - | 1 | Apr 10, 2026 |
Alterity Therapeutics
Aug 11, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $4.55
Upside: +164.03%
Aclaris Therapeutics
Aug 6, 2026
Maintained: Buy
Price Target: $10
Current: $5.90
Upside: +69.49%
PepGen
Aug 6, 2026
Maintained: Buy
Price Target: $11
Current: $2.99
Upside: +267.89%
Design Therapeutics
Aug 4, 2026
Maintained: Buy
Price Target: $22
Current: $14.33
Upside: +53.52%
MapLight Therapeutics
Jul 28, 2026
Maintained: Buy
Price Target: $40 → $25
Current: $12.18
Upside: +105.25%
Apogee Therapeutics
Jun 22, 2026
Downgraded: Hold
Price Target: $114 → $135
Current: $134.65
Upside: +0.34%
Immunome
Jun 11, 2026
Rated: Buy
Price Target: $36
Current: $25.69
Upside: +40.13%
LB Pharmaceuticals
Jun 11, 2026
Rated: Buy
Price Target: $36
Current: $45.85
Upside: -21.48%
Health In Tech
Apr 10, 2026
Maintained: Buy
Price Target: n/a
Current: $1.12
Upside: -